{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:47:11Z","timestamp":1782402431640,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0529400 & 2024ZD0529406"],"award-info":[{"award-number":["2024ZD0529400 & 2024ZD0529406"]}]},{"name":"New Chongqing Youth Innovation Talent Project","award":["CSTB2024NSCQ-QCXMX0031"],"award-info":[{"award-number":["CSTB2024NSCQ-QCXMX0031"]}]},{"name":"Chongqing Science and Health Joint Medical Science and Technology Innovation and Key Project","award":["2025GGXM001"],"award-info":[{"award-number":["2025GGXM001"]}]},{"name":"Key Project of the Joint Fund for Regional Innovation and Development under the National Natural Science Foundation of China","award":["U24A20715"],"award-info":[{"award-number":["U24A20715"]}]},{"name":"Hematopoietic Acute Radiation Syndrome Medical and Pharmaceutical Basic Research Innovation Center, Ministry of Education of the People\u2019s Republic of China","award":["ARSBIC-B-202405"],"award-info":[{"award-number":["ARSBIC-B-202405"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08357-x","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:24:09Z","timestamp":1780161849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ABCC2 as a novel therapeutic target in lung adenocarcinoma: a machine learning-driven discovery linking ammonia metabolism to prognosis and drug resistance"],"prefix":"10.1186","volume":"24","author":[{"given":"Shuangqing","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3699-8138","authenticated-orcid":false,"given":"Jigang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6725-385X","authenticated-orcid":false,"given":"Quanxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"3","key":"8357_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"8357_CR2","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","journal-title":"J Natl Cancer Cent"},{"issue":"9","key":"8357_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"8357_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, et al. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535\u201346.","journal-title":"Nat Rev Cancer"},{"key":"8357_CR5","doi-asserted-by":"crossref","unstructured":"Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1\u201324.","DOI":"10.1016\/j.ccm.2019.10.001"},{"issue":"5","key":"8357_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pulmoe.2020.02.005","volume":"26","author":"R Pirker","year":"2020","unstructured":"Pirker R. Conquering lung cancer: current status and prospects for the future. Pulmonology. 2020;26(5):283\u201390.","journal-title":"Pulmonology"},{"issue":"10","key":"8357_CR7","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017;36(10):1302\u201315.","journal-title":"EMBO J"},{"key":"8357_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","volume":"15","author":"M Holecek","year":"2018","unstructured":"Holecek M. Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutr Metab (Lond). 2018;15:33.","journal-title":"Nutr Metab (Lond)"},{"issue":"119","key":"8357_CR9","doi-asserted-by":"publisher","first-page":"ra31","DOI":"10.1126\/scisignal.2000911","volume":"3","author":"CH Eng","year":"2010","unstructured":"Eng CH, et al. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal. 2010;3(119):ra31.","journal-title":"Sci Signal"},{"issue":"9","key":"8357_CR10","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1016\/j.apsb.2023.02.016","volume":"13","author":"H Tian","year":"2023","unstructured":"Tian H, et al. Bladder microenvironment actuated proteomotors with ammonia amplification for enhanced cancer treatment. Acta Pharm Sin B. 2023;13(9):3862\u201375.","journal-title":"Acta Pharm Sin B"},{"issue":"7656","key":"8357_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature22359","volume":"546","author":"J Kim","year":"2017","unstructured":"Kim J, et al. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS\/LKB1-mutant lung cancer cells. Nature. 2017;546(7656):168\u201372.","journal-title":"Nature"},{"issue":"6365","key":"8357_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1126\/science.aam9305","volume":"358","author":"JB Spinelli","year":"2017","unstructured":"Spinelli JB, et al. Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science. 2017;358(6365):941\u20136.","journal-title":"Science"},{"issue":"11","key":"8357_CR13","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41556-024-01503-x","volume":"26","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8(+) T cells. Nat Cell Biol. 2024;26(11):1892\u2013902.","journal-title":"Nat Cell Biol"},{"issue":"18","key":"8357_CR14","first-page":"4124","volume":"56","author":"K Taniguchi","year":"1996","unstructured":"Taniguchi K, et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 1996;56(18):4124\u20139.","journal-title":"Cancer Res"},{"issue":"12","key":"8357_CR15","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.7150\/ijbs.97425","volume":"20","author":"R Zhang","year":"2024","unstructured":"Zhang R, et al. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m(6)A-YTHDF1-dependent manner. Int J Biol Sci. 2024;20(12):4750\u201366.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"8357_CR16","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1002\/ctm2.1754","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer. Clin translational Med. 2024;14(8):e1754\u20131754.","journal-title":"Clin translational Med"},{"issue":"1","key":"8357_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41467-024-55810-w","volume":"16","author":"E Koide","year":"2025","unstructured":"Koide E, et al. Structural basis for the transport and regulation mechanism of the multidrug resistance-associated protein 2. Nat Commun. 2025;16(1):484\u2013484.","journal-title":"Nat Commun"},{"key":"8357_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1755-8794-5-22","volume":"5","author":"J Staaf","year":"2012","unstructured":"Staaf J, et al. Relation between smoking history and gene expression profiles in lung adenocarcinomas. BMC Med Genomics. 2012;5:22.","journal-title":"BMC Med Genomics"},{"issue":"186","key":"8357_CR19","doi-asserted-by":"publisher","first-page":"186ra66","DOI":"10.1126\/scitranslmed.3005723","volume":"5","author":"S Rousseaux","year":"2013","unstructured":"Rousseaux S, et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med. 2013;5(186):186ra66.","journal-title":"Sci Transl Med"},{"issue":"1","key":"8357_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","volume":"72","author":"H Okayama","year":"2012","unstructured":"Okayama H, et al. Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas. Cancer Res. 2012;72(1):100\u201311.","journal-title":"Cancer Res"},{"issue":"8","key":"8357_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neo.2020.04.005","volume":"22","author":"SK Hight","year":"2020","unstructured":"Hight SK, et al. An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis. Neoplasia. 2020;22(8):294\u2013310.","journal-title":"Neoplasia"},{"issue":"1","key":"8357_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/JTO.0000000000000042","volume":"9","author":"SD Der","year":"2014","unstructured":"Der SD, et al. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. J Thorac Oncol. 2014;9(1):59\u201364.","journal-title":"J Thorac Oncol"},{"issue":"19","key":"8357_CR23","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1200\/JCO.2012.44.3762","volume":"31","author":"F Ulloa-Montoya","year":"2013","unstructured":"Ulloa-Montoya F, et al. Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy. J Clin Oncol. 2013;31(19):2388\u201395.","journal-title":"J Clin Oncol"},{"issue":"7","key":"8357_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ccell.2021.05.009","volume":"39","author":"L Pusztai","year":"2021","unstructured":"Pusztai L, et al. Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II\/III breast cancer: Results from the adaptively randomized I-SPY2 trial. Cancer Cell. 2021;39(7):989\u2013e9985.","journal-title":"Cancer Cell"},{"issue":"1","key":"8357_CR25","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","volume":"10","author":"H Jung","year":"2019","unstructured":"Jung H, et al. DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat Commun. 2019;10(1):4278.","journal-title":"Nat Commun"},{"issue":"11","key":"8357_CR26","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","volume":"54","author":"J Zhu","year":"2022","unstructured":"Zhu J, et al. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. Exp Mol Med. 2022;54(11):2060\u201376.","journal-title":"Exp Mol Med"},{"issue":"2","key":"8357_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41591-019-0750-6","volume":"26","author":"AM Laughney","year":"2020","unstructured":"Laughney AM, et al. Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nat Med. 2020;26(2):259\u201369.","journal-title":"Nat Med"},{"issue":"1","key":"8357_CR28","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.","journal-title":"Nat Commun"},{"key":"8357_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"8357_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"key":"8357_CR31","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/j.csbj.2024.06.035","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu H, et al. Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection. Comput Struct Biotechnol J. 2024;23:2798\u2013810.","journal-title":"Comput Struct Biotechnol J"},{"key":"8357_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"8357_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"8357_CR34","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"key":"8357_CR35","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1016\/j.ymthe.2024.09.025","volume":"32","author":"WN Liu","year":"2024","unstructured":"Liu WN, et al. Single-cell RNA sequencing reveals anti-tumor potency of CD56\u2009+\u2009NK cells and CD8\u2009+\u2009T cells in humanized mice via PD-1 and TIGIT co-targeting. Mol Ther. 2024;32:3895\u2013914.","journal-title":"Mol Ther"},{"key":"8357_CR36","doi-asserted-by":"publisher","first-page":"215583","DOI":"10.1016\/j.canlet.2022.215583","volume":"532","author":"Y Shi","year":"2022","unstructured":"Shi Y, et al. TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression. Cancer Lett. 2022;532:215583.","journal-title":"Cancer Lett"},{"issue":"1","key":"8357_CR37","doi-asserted-by":"publisher","first-page":"23243","DOI":"10.1038\/s41598-024-74336-1","volume":"14","author":"Y Si","year":"2024","unstructured":"Si Y, et al. RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature. Sci Rep. 2024;14(1):23243.","journal-title":"Sci Rep"},{"key":"8357_CR38","doi-asserted-by":"publisher","first-page":"155820","DOI":"10.1016\/j.cyto.2022.155820","volume":"152","author":"J Chen","year":"2022","unstructured":"Chen J, et al. Hypoxia-related gene signature for predicting LUAD patients\u2019 prognosis and immune microenvironment. Cytokine. 2022;152:155820.","journal-title":"Cytokine"},{"issue":"1","key":"8357_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12859-023-05137-y","volume":"24","author":"H Feng","year":"2023","unstructured":"Feng H, et al. Genomic and immunogenomic analysis of three prognostic signature genes in LUAD. BMC Bioinformatics. 2023;24(1):19.","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"8357_CR40","doi-asserted-by":"publisher","first-page":"152751","DOI":"10.1016\/j.imbio.2023.152751","volume":"228","author":"C Song","year":"2023","unstructured":"Song C, et al. Identification and validation of a novel NK cells-related signature to predict prognosis and immune microenvironment in LUAD. Immunobiology. 2023;228(6):152751.","journal-title":"Immunobiology"},{"issue":"1","key":"8357_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40164-023-00388-0","volume":"12","author":"L Zhang","year":"2023","unstructured":"Zhang L, et al. Complement-related molecular classification and a gene signature for lung adenocarcinoma. Experimental Hematol Oncol. 2023;12(1):22.","journal-title":"Experimental Hematol Oncol"},{"key":"8357_CR42","doi-asserted-by":"publisher","first-page":"1179742","DOI":"10.3389\/fimmu.2023.1179742","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma. Front Immunol. 2023;14:1179742.","journal-title":"Front Immunol"},{"key":"8357_CR43","doi-asserted-by":"publisher","first-page":"1201573","DOI":"10.3389\/fimmu.2023.1201573","volume":"14","author":"Q Ren","year":"2023","unstructured":"Ren Q, et al. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts. Front Immunol. 2023;14:1201573.","journal-title":"Front Immunol"},{"key":"8357_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.omto.2020.09.011","volume":"19","author":"L He","year":"2020","unstructured":"He L, et al. Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma. Mol therapy oncolytics. 2020;19:265\u201377.","journal-title":"Mol therapy oncolytics"},{"key":"8357_CR45","doi-asserted-by":"publisher","first-page":"963220","DOI":"10.3389\/fendo.2022.963220","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma. Front Endocrinol. 2022;13:963220.","journal-title":"Front Endocrinol"},{"issue":"1","key":"8357_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12935-023-03125-z","volume":"23","author":"X Ma","year":"2023","unstructured":"Ma X, et al. Leveraging a disulfidptosis\/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma. Cancer Cell Int. 2023;23(1):267.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"8357_CR47","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1186\/s12885-023-11415-y","volume":"23","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Immune characteristics analysis and construction of a four-gene prognostic signature for lung adenocarcinoma based on estrogen reactivity. BMC Cancer. 2023;23(1):1047.","journal-title":"BMC Cancer"},{"key":"8357_CR48","doi-asserted-by":"publisher","first-page":"616271","DOI":"10.3389\/fcell.2021.616271","volume":"9","author":"A Zhang","year":"2021","unstructured":"Zhang A, et al. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma. Front cell Dev biology. 2021;9:616271.","journal-title":"Front cell Dev biology"},{"issue":"3","key":"8357_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41571-020-00432-6","volume":"18","author":"M Oudkerk","year":"2021","unstructured":"Oudkerk M, et al. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives. Nat Rev Clin Oncol. 2021;18(3):135\u201351.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"8357_CR50","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345\u201356.","journal-title":"Nat Med"},{"key":"8357_CR51","doi-asserted-by":"crossref","unstructured":"Chen G, et al. Novel roles of ammonia in physiology and cancer. J Mol Cell Biol. 2025;17(1).","DOI":"10.1093\/jmcb\/mjaf007"},{"key":"8357_CR52","doi-asserted-by":"crossref","unstructured":"Dai W, et al. Glutamine synthetase limits beta-catenin-mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1. J Clin Invest. 2022;132(24).","DOI":"10.1172\/JCI161408"},{"issue":"5","key":"8357_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s42255-022-00568-y","volume":"4","author":"C Cheng","year":"2022","unstructured":"Cheng C, et al. Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. Nat Metab. 2022;4(5):575\u201388.","journal-title":"Nat Metab"},{"issue":"1","key":"8357_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cmet.2022.11.013","volume":"35","author":"HN Bell","year":"2023","unstructured":"Bell HN, et al. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metab. 2023;35(1):134\u2013e1496.","journal-title":"Cell Metab"},{"issue":"6","key":"8357_CR55","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan AC, Tan DSW. Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations. J Clin Oncol. 2022;40(6):611\u201325.","journal-title":"J Clin Oncol"},{"key":"8357_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejps.2017.03.002","volume":"103","author":"JM Pedersen","year":"2017","unstructured":"Pedersen JM, et al. Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2). Eur J Pharm Sci. 2017;103:70\u20136.","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"8357_CR57","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.21037\/tlcr-23-567","volume":"12","author":"Z Wang","year":"2023","unstructured":"Wang Z, et al. PFKP confers chemoresistance by upregulating ABCC2 transporter in non-small cell lung cancer. Transl Lung Cancer Res. 2023;12(11):2294\u2013309.","journal-title":"Transl Lung Cancer Res"},{"issue":"23","key":"8357_CR58","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1158\/0008-5472.CAN-21-0980","volume":"81","author":"X Chen","year":"2021","unstructured":"Chen X, et al. The HNF4alpha-BC200-FMR1-Positive Feedback Loop Promotes Growth and Metastasis in Invasive Mucinous Lung Adenocarcinoma. Cancer Res. 2021;81(23):5904\u201318.","journal-title":"Cancer Res"},{"key":"8357_CR59","doi-asserted-by":"publisher","first-page":"136093","DOI":"10.1016\/j.jhazmat.2024.136093","volume":"480","author":"Y Xie","year":"2024","unstructured":"Xie Y, et al. m(6)A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression. J Hazard Mater. 2024;480:136093\u2013136093.","journal-title":"J Hazard Mater"},{"issue":"5","key":"8357_CR60","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-021-03733-5","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, et al. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by beta-catenin and Beclin1\/autophagy signaling in colorectal cancer. Cell Death Dis. 2021;12(5):449.","journal-title":"Cell Death Dis"},{"issue":"2","key":"8357_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2789","volume":"10","author":"JI Fletcher","year":"2010","unstructured":"Fletcher JI, et al. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10(2):147\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"8357_CR62","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"8357_CR63","first-page":"74","volume-title":"T cell exclusion, immune privilege, and the tumor microenvironment","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Volume 348. New York, N.Y.): Science; 2015. pp. 74\u201380. 6230."},{"issue":"5","key":"8357_CR64","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08357-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:03:47Z","timestamp":1782399827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08357-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8357"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08357-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the GB\/T 35892\u2009\u2212\u20092018 Laboratory animal \u2014 Guideline for ethical review of animal welfare (Standardization Administration of China), the ARRIVE 2.0 guidelines, and the 3R principles. The experimental protocol was reviewed and approved by the Laboratory Animal Welfare and Ethics Committee of the Army Medical University (AMUWEC20255419). Our IHC sections have been approved by the ethics review board of Aifang Biological Company (Changsha, China; HN20250401).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not commissioned, externally peer-reviewed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Provenance and peer review"}},{"value":"This study does not involve.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient or volunteer consent"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"816"}}